Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
InsideHealthPolicy: Patient Advocates Worry GUARD Model Will Impede HIV Drug Access
As CMS reviews the comments its received from HIV+HEP and other stakeholders on the GUARD model, new analysis from the advocacy organization Patients for Affordable Drugs (P4AD) found the United States pays the highest prices in the world for antiretroviral drugs, as median costs exceed $35,000 annually and have been rising faster than the rate of inflation […]
News and Reports
Epoch Times: How the High Cost of Health Care Hurts Patients
Kevin Baker, 23, of Eugene, Oregon, takes medication to control Crohn’s disease. The prescription costs more than $6,500 per month. The medication is under patent, so it’s available from only one manufacturer. Baker has health insurance, but his insurer refused to pay for the drug. And although the manufacturer provides financial assistance to some patients, […]
News and Reports
STAT News: A month in, TrumpRx falls short of president’s grand promises
“For several patients in our community, TrumpRx prices are the same or even higher than what they currently pay with insurance,” Merith Basey, executive director of Patients For Affordable Drugs, said in a statement to STAT. “While continued efforts to lower prescription drug prices are encouraged, this program’s design does not address the root cause […]
News and Reports
WSOC-TV: Action 9: Ways to save more on your meds
Emmabella Rudd has diabetes. Her struggle to get insulin led her to become a patient advocate for affordable drugs “Being a patient, especially in the United States, relying on a prescription drug to survive, is, you know, navigating hurdles day to day, and that can be extremely frustrating,” she said. It’s not surprising to Merith […]
News and Reports
Washington Post: Lower drug prices: Just the beginning
On a recent WP Intelligence Live Briefing, “Washington’s new push on drug pricing,” Patients For Affordable Drugs CEO Merith Basey explained why Medicare’s new negotiation authority is already delivering life-changing savings for seniors and why advocates see this as just the beginning of broader reform. Watch the full briefing here: https://www.youtube.com/watch?v=CXH2CVa9YsU
News and Reports
Epoch Times: Trump Asks Congress to Codify His Drug Price Policy Into Law
Details of the voluntary agreements have not been made public, so the full number and amount of price reductions are not known. “These arrangements do not automatically lower drug prices across the entire system, nor do they apply to most high-cost or widely used medications,” Merith Basey, CEO of Patients for Affordable Drugs, said in […]
News and Reports
Washington Post Health Brief: ICYMI: A WP Intelligence briefing
Guests Merith Basey, the CEO of Patients for Affordable Drugs, and Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President of Policy and Research Elizabeth Carpenter talked about the impacts of Medicare price negotiations, pharmacy benefit manager (PBM) reform, rising launch prices and what’s coming next on policy.
News and Reports
Barron’s: TrumpRx Is Here. Most People Won’t Benefit
The discounts came via negotiations between the Trump administration and drug manufacturers that aren’t codified into law, said Merith Basey, CEO of Patients for Affordable Drugs, an advocacy group. Basey says key questions for patients are how long will the discounts be available, will prices be subject to change, and will pharmacies honor them?